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Abstract
Gammaherpesviruses chronically infect their host and are tightly associated with the development of lymphoproliferative
diseases and lymphomas, as well as several other types of cancer. Mechanisms involved in maintaining chronic
gammaherpesvirus infections are poorly understood and, in particular, little is known about the mechanisms involved in
controlling gammaherpesvirus reactivation from latently infected B cells in vivo. Recent evidence has linked plasma cell
differentiation with reactivation of the human gammaherpesviruses EBV and KSHV through induction of the immediate-early
viral transcriptional activators by the plasma cell-specific transcription factor XBP-1s. We now extend those findings to
documenta role for agammaherpesvirusgeneproductinregulatingplasmacell differentiation and thusvirusreactivation.We
have previously shown that the murine gammaherpesvirus 68 (MHV68) gene product M2 is dispensable for virus replication in
permissive cells, but plays a critical role in virus reactivation from latently infected B cells. Here we show that in mice infected
with wild type MHV68, virus infected plasma cells (ca. 8% of virus infected splenocytes at the peak of viral latency) account for
the majority of reactivation observed upon explant of splenocytes. In contrast, there is an absence of virus infected plasma
cellsatthe peak of latency inmiceinfected witha M2nullMHV68. Furthermore,we show thatthe M2protein candriveplasma
cell differentiation in a B lymphoma cell line in the absence of any other MHV68 gene products. Thus, the role of M2 in MHV68
reactivationcanbeattributed toitsability to manipulateplasmacell differentiation, providing a novel viralstrategytoregulate
gammaherpesvirus reactivation from latentlyinfected B cells.We postulatethat M2 represents a new class of herpesvirus gene
products(reactivationconditioners)thatdonotdirectlyparticipateinvirusreplication,butratherfacilitatevirusreactivationby
manipulating the cellular milieu to provide a reactivation competent environment.
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Introduction
Plasma cells, which are the cellular factories that produce
secreted antibody, play a critical role in mounting an effective
immune response to many pathogens. Early plasma cell responses
to foreign antigens can be divided into two phases: (i)
differentiation of short-lived plasma cells arising from naı ¨ve
marginal-zone and mature follicular B cells, which secrete low
affinity antibodies that have not undergone somatic mutation and
are thought to provide an initial rapid response to the invading
pathogen; and (ii) differentiation of follicular B cells upon
encountering antigen and receiving T cell help, leading to the
formation of germinal centers, several rounds of B cell prolifer-
ation, affinity maturation, class-switching, and ultimately the
development of memory B cells and plasma cells that serve to
sustain humoral immune responses [1]. Although the signal(s) that
initiate plasma cell differentiation remain controversial, recent
progress has identified several critical transcriptional regulators of
plasma cell differentiation - including B lymphocyte induced
maturation protein 1 (Blimp-1), interferon regulatory factor-4
(IRF-4) and XBP-1s [2,3,4,5,6].
Crawford and Ando [7] provided early evidence that Epstein-
Barr virus (EBV) replication-associated antigens were present in
Burkitt’s lymphoma cells that exhibited a plasma cell phenotype –
providing the first evidence that plasma cell differentiation is
associated with virus reactivation from latency. More recently this
observation has been extended to show that plasma cell
differentiation is associated with reactivation of both EBV and
Kaposi’s sarcoma-associated herpesvirus (KSHV). Induction of
EBV and KSHV replication in latently infected B cells appears to
be driven by the plasma cell-specific transcription factor XBP-1s,
which activates transcription of the viral immediate-early genes
encoding the critical transcriptional activators that trigger the EBV
and KSHV replication cascades (BZLF1 and BRLF1/gene 50 in
the EBV genome and gene 50 in the KSHV genome)
[8,9,10,11,12]. Whether plasma cell differentiation leading to
virus reactivation is a common strategy utilized by B cell-tropic
gammaherpesviruses remains to be determined.
Murine gammaherpesvirus 68 (MHV68) infection of mice
provides a tractable small animal model to investigate basic issues
of gammaherpesvirus pathogenesis. Previous characterizations of
MHV68 latency in mice have shown that B cells, as well as some
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- with B cells appearing to represent the major long term latency
reservoir [13,14,15,16,17]. Analyses of virus latency in the spleen
have shown that during the establishment of latency MHV68 is
found in naive, germinal center and memory B cells [14,18].
However, latency in naive and germinal center B cells wanes with
time and at late times post-infection MHV68, like EBV, is
predominantly found in memory B cells [14,18]. Recently, we
have also identified MHV68 in plasma cells at the peak of virus
latency in the spleen [19]. The latter observation raises the
possibility that, like EBV and KSHV, plasma cell differentiation
may be associated with MHV68 reactivation.
Here we demonstrate that plasma cell differentiation is linked to
MHV68 reactivation from latency. In addition, we provide
evidence that a MHV68 encoded gene product, M2, plays a
seminal role in virus gaining access to plasma cells. We have
previously shown that the MHV68 M2 protein, which is expressed
in a subset of infected B cells at the peak of viral latency [20], plays
critical roles in both the establishment of latency as well as virus
reactivation from latently infected B cells - phenotypes that are
influenced by both route and dose of virus inoculation [18,21].
Additionally, efficient transition of latently-infected B cells from
the germinal center reaction to the memory B cell reservoir
appears to be stalled in the absence of M2, suggesting M2 may
manipulate B cell signaling or differentiation to facilitate
establishment of long-term latency in the memory B cell pool
[18,22]. Importantly, M2 is dispensable for virus replication in
permissive fibroblasts in vitro or during acute virus replication in
the lungs following intranasal inoculation [21]. Thus, M2 appears
to have a specialized role during establishment of latency and
reactivation. M2 contains several SH3 domain docking sites, along
with 2 functionally important tyrosine residues that are targets for
phosphorylation, and is thought to function as a molecular scaffold
that modulates B cell signaling pathways [23,24]. Notably, M2 has
been shown to target phosphorylation of the guanosine nucleotide
exchange factors Vav1 and Vav2, and more recently has been
shown form a trimolecular complex with Vav1 and the Src family
tyrosine kinase Fyn [24] - although the functional consequences of
these interactions remain unclear. Here we focus on the role of M2
in virus reactivation from B cells.
Results
M2 is required for efficient virus reactivation from latently
infected B cell lines in vitro
To begin characterizing the role that M2 plays in virus
reactivation from latently infected B cells, we initially determined
whether a requirement for M2 in MHV68 reactivation from
latently infected B cells could be recapitulated in a tissue culture
B cell latency model. Utilizing the murine M12 B lymphoma
cell line, we generated a number of clonal cell lines harboring
either a recombinant wild type MHV68 containing a hygro-
mycin-GFP fusion protein expression cassette, or a M2-null
MHV68 mutant (M2.Stop) on the same genetic background
(Fig. 1A). Stable cell lines were generated using hygromycin
selection, and then analyzed for virus reactivation following
stimulation with the phorbol ester TPA. Notably, TPA treatment
induced significant virus reactivation in all the M12 clones
infected with wild type MHV68 - as shown by both immunoblot
analyses of expression of MHV68 replication-associated antigens
(Fig. 1B) and increased titers of infectious virus in the tissue
culture supernatants (Fig. 1C). In contrast, TPA treatment of
M12 cell lines infected with the M2.Stop virus resulted in little
increase in virus replication (Fig. 1B and 1C). Similarly,
treatment with either 5-azacytidine or trichostatin A was able
to induce reactivation of the wild type MHV68 M12 cell lines,
but not the M2.Stop infected clones (data not shown).
Importantly, ectopic expression of M2 rescued virus reactivation
from the M2.Stop infected M12 cell lines (Fig. 1D) - indeed,
expression of M2 alone in the absence of TPA induction resulted
in a significant increase in the expression of replication-associated
viral antigens from both wild type and M2.Stop infected M12 cell
lines. The ability of ectopic M2 expression to drive MHV68
reactivation was not limited to the latently infected M12 cell lines,
but independently observed with latently infected murine A20 B
lymphoma cell lines (data not shown). The latter results suggest a
direct link between M2 expression and MHV68 reactivation
from latently infected B cells.
Although M2 is completely dispensable for MHV68 replication
in permissive cell lines [18,21], we next assessed whether it might
play a B cell-specific role in activating transcription from the
immediate-early gene 50 promoter which encodes the essential
lytic switch protein RTA. To assess whether M2 could directly
activate the immediate-early gene 50, we used reporter constructs
in which the proximal gene 50 promoter was cloned upstream of a
firefly luciferase reporter gene. We have previously shown that the
proximal gene 50 promoter is required for reactivation of MHV68
from latently infected B cells [25]. Notably, M2 expression (in the
absence of other viral proteins) could only weakly upregulated
(,3-fold) gene 50 promoter activity (data not shown), indicating
that the role of M2 in virus reactivation from the latently infected
M12 B cell lines is unlikely to be via direct targeting/regulation of
gene 50 transcription. As such, we turned our attention to further
investigating the impact of loss of M2 expression on virus infection
in vivo.
Author Summary
Gammaherpesviruses are associated with the develop-
ment of lymphomas, particularly in immunosuppressed
individuals, as well as several other types of cancers. Like
all herpesviruses, once a host is infected these viruses
cannot be cleared and, as such, infected individuals harbor
these viruses for life. One of the important strategies
utilized by herpesviruses to chronically infect their host is
their ability to establish a largely quiescent form of
infection referred to as latency, in which no progeny virus
is produced. Importantly, all herpesviruses have the
capacity to emerge from latency and replicate, a process
referred to as reactivation. Gammaherpesviruses largely
persist in a population of white blood cells called B
lymphocytes which, upon differentiation into plasma cells,
produce antibodies in response to infection. Notably, it has
been recently shown for the human gammaherpesviruses,
Epstein-Barr virus and Kaposi’s sarcoma-associated her-
pesvirus, that virus reactivation from latently infected B
lymphocytes involves differentiation of the infected B
lymphocytes to plasma cells. Here, using a small animal
model of gammaherpesvirus infection, we show that
plasma cell differentiation is also associated with reactiva-
tion of murine gammaherpesvirus 68. Furthermore, we
show that this requires a protein encoded by the virus
which is able to drive plasma cell differentiation. Thus, our
studies not only confirm the importance of plasma cell
differentiation in gammaherpesvirus reactivation from B
lymphocytes, but also provide evidence that this process is
controlled by a viral protein.
MHV68 M2-Driven Plasma Cell Differentiation
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distribution in marginal zone, follicular and newly formed
B cell populations in the spleen at the peak of virus
latency
To track MHV68 latently infected B cell populations in vivo, we
generated a recombinant MHV68 harboring an enhanced yellow
fluorescent protein (eYFP) transgene under the control of the
HCMV immediate-early promoter and enhancer (MHV68-YFP)
[19]. We have extensively characterized the MHV68-YFP
recombinant virus and have shown that it behaves like wild type
virus and is able to efficiently mark latently infected cells at the
peak of viral latency (days 16–18 post-infection) [19]. For our
studies on M2 function we generated an M2 null MHV68
harboring the eYFP expression cassette (M2.Stop-YFP), which is
described below, as well generating and characterizing a
recombinant MHV68 with an AU1 epitope tag fused to the C-
terminus of M2 [MHV68-YFP(M2.AU1)]. To ensure that
insertion of the eYFP expression cassette did not adversely impact
the M2 null virus phenotype, we compared infection of mice with
either the previously characterized M2.Stop mutant virus [18], the
M2.Stop-YFP virus, or MHV68-YFP virus, followed by analysis of
establishment latency and reactivation at day 16 post-infection. In
addition, since the analyses of M2 function discussed above used
an M2 expression vector in which an AU1 epitope tag was inserted
at the C-terminus of M2, we also generated and characterized a
recombinant MHV68 in harboring the AU1 epitope tagged M2
[MHV68-YFP(M2.AU1)]. These analyses demonstrated that the
phenotype of the eYFP expressing M2 null virus was indistin-
guishable from the well characterized M2.Stop mutant virus
(Fig. 2A and 2B). In addition, the insertion of an AU1 epitope tag
did not appear to have any impact on the phenotype of the
MHV68-YFP virus (Fig. 2A and 2B).
We next sought to characterize and compare B cell populations
harboring wild type or M2 null MHV68 (M2.Stop)in infected mice.
Theinfected spleenswereharvested at day16post-infection and the
presence of virus in distinct B cell populations was assessed by flow
cytometry. Analyses of total splenoctyes revealed equivalent levels of
marginal zone B cells (CD21
hiCD23
lo) in infected and naı ¨ve mice,
but slightly lower levels of follicular B cells (CD21
hiCD23
hi) coupled
with a slight increase in newly formed B cells (CD21
loCD23
lo)i n
miceinfected with eitherwild typeorM2nullMHV68 comparedto
naı ¨ve mice (Fig. 2C). Analysis of the distribution of virus in these B
cell populations revealed that M2 null virus infection, like wild type
MHV68, was present in each of these B cell populations (Fig. 2D).
However, the M2 null virus was diminished in marginal zone B cells
and elevated in follicular B cells compared to wild type MHV68
(Fig. 2D). As we have previously noted [19], the pattern of CD21
and CD23 surface expression on MHV68 infected cells is somewhat
distinct from that observed in naı ¨ve mice. Indeed, it has been shown
that both CD21 and CD23 expression can be modulated by EBV,
KSHV and MHV68 [26,27] (C.M. Collins and S.H. Speck.,
unpublished data). Thus, some caution must be taken in
interpreting the distribution of wild type and M2 null MHV68 in
these splenic B cell populations. Finally, although we observed
decreased levels of activatedB cells(CD19
+CD69
hi) in the spleens of
Figure 1. Requirement of MHV68 M2 protein for efficient reactivation from B cell latency. (A) Schematic illustration MHV68 recombinant
viruses harboring a hygromycin phosphotransferase gene fused to EGFP (Hygro-EGFP) in the neutral locus of either wild type (WT-HE) or an M2-null
mutant virus (M2.Stop-HE). (B) Latently infected WT-HE and M2.Stop-HE M12 cells were either mock treated or stimulated with TPA and expression of
viral replication-associated antigen detected with either an anti-MHV68 serum generated in infected rabbits or antibodies raised against a peptide
from the replication-associated ORF59 encoded viral antigen. Antibodies against tubulin were used to control for amount of cell lysate loaded. (C)
Virus production from WT-HE and M2.stop-HE M12 cells as a function of time post-TPA stimulation. Virus titers were determined by plaque assay on
NIH 3T3 fibroblasts as previously described [38]. (D) WT or M2.Stop-HE M12 cells were either mock treated or stimulated with TPA at 24 hr post-
transfection with an M2 expression plasmid (pEF/M2-AU1) or the parental empty expression vector (pEF). Cell lysates harvested at 24 hr post-TPA
induction were analyzed by immunoblotting using a rabbit anti-MHV68 antiserum generated from MHV68 infected rabbits [38].
doi:10.1371/journal.ppat.1000677.g001
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MHV68-YFP infected mice (which correlates with a less robust
establishment of splenic latency in M2.Stop infected mice), a similar
percentage (ca. 40%) of virus infected B cells (YFP+) exhibited an
activated phenotype in M2.Stop-YFP and wild type MHV68-YFP
infected mice (Fig. 2E).
Figure 2. Distribution of M2 null virus in newly formed, marginal zone and follicular B cells in the spleen at the peak of latency is
similar to wild type MHV68. (A and B) Insertion of a YFP expression cassette into the viral genome, or addition of an AU1 epitope tag on the C-
terminus of M2, did not alter the phenotype of the M2 null virus. Latency and reactivation phenotypes of several YFP expressing MHV68 recombinant
viruses were assessed using standard limiting dilution analyses to compare the eYFP expressing M2.Stop recombinant virus to the well characterized
M2.Stop mutant, as well as different wt YFP expressing viruses - one of which contains an AU1 epitope tag on the C-terminus of M2. All data were
pooled from two independent virus isolate, five mice infected with 100 pfu of the indicated virus via intranasal inoculation. (A) Limiting dilution PCR
analyses of the frequency of splenocytes harboring viral genome following infection with the indicated recombinant viruses. (B) Limiting dilution
analyses of MHV68 reactivation following explant of splenocytes harvested at day 16 post-infection. (C) Similar levels of marginal zone (MZ), follicular
(FC) and newly formed (NF) B cells in spleens infected with wt MHV68-YFP or M2 null viruses (M2.stop-YFP). (D) Percentage of MZ, FC and NF B cells in
virus infected (YFP+ cells) splenocytes with wt MHV68-YFP or M2 null viruses. (E) Percentage of activated B cells present in wt MHV68-YFP or M2 null
virus infected spleen cells at day 16 post-infection. The p values indicated in the figure were determined by two-tailed, unpaired t test with a 95%
confidence level.
doi:10.1371/journal.ppat.1000677.g002
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cells into germinal centers, but the absence of M2 leads
to alterations in immunoglobulin isotype class switching
Comparing establishment of B cell latency in the spleen using
wild type MHV68-YFP and M2.Stop-YFP recombinant viruses,
we observed a smaller germinal center response in mice infected
with the M2.Stop-YFP virus at day 16 post-infection (Fig. 3A and
3B). However, even though there was a diminished germinal
center response (coupled with a lower frequency of M2.Stop-YFP
infected B cells compared to MHV68-YFP infected mice), when
we examined the distribution of virus infected cells we observed
that a very similar percentage of wild type and M2.Stop virus
infected B cells exhibited a germinal center phenotype (GL7
+/
CD95
+)( Fig. 3C and 3D). This substantiates earlier analyses
demonstrating the ability of M2 null viruses to form and expand
within germinal centers [18,22].
Examination of immunoglobulin isotype class switching in the
spleens of MHV68-YFP and M2.Stop-YFP infected mice revealed
a significant difference in the presence of B cells that had switched
to IgG2a, the predominant IgG subtype observed following
MHV68 infection (unpublished data) as well as many other viral
infections [28]. While approximately 6% of splenic B cells were
IgD2/IgG2a+ following MHV68-YFP infection, ,1% had
switched to IgG2a following infection with the M2.Stop-YFP
virus (Fig. 3E). Furthermore, approximately 50% of wild type
MHV68-YFP was found in IgG2a+ B cells while ,10% of
M2.Stop-YFP virus was in IgG2a+ B cells (Fig. 3F). These results
are consistent with our previous analyses indicating that the
M2.Stop virus is impaired in gaining access to isotype switched B
cells [18]. These results implicate a role for M2 in modulating
immunoglobulin isotype class switching.
M2 is required for differentiation of MHV68 infected B
cells to plasma cells
Based on the recently established link between plasma cell
differentiation and gammaherpesvirus reactivation [8,9,10,11,12],
we assessed the presence of MHV68 in plasma cells at the peak of
splenic latency (days 16–18 post-infection). We analyzed individual
mice infected with wild type MHV68-YFP or M2.Stop-YFP for
the presence of virus infected plasma cells (YFP+/B220
lo/2/
CD138
+). Consistently, in mice infected with MHV68-YFP,
approximately 8% of virus infected B cells were plasma cells at
day 16 post-infection (Fig. 4A and 4C). In stark contrast, #1.5% of
M2.Stop-YFP virus infected B cells were plasma cells (Fig. 4A and
4C). Notably, analysis of bulk splenocytes revealed that the
frequency of plasma cells in the spleens of wild type and M2 null
virus infected mice were relatively comparable (approximately
1.5%), and slightly higher than the levels observed in naive mice
(about 0.5%) (Fig. 4B). Finally, we used a functional assay to
directly assess the presence of wild type MHV68 in plasma cells.
YFP+ splenocytes were isolated by flow cytometry and analyzed by
ELISPOT to determine the frequency of antibody secreting cells
(ASC). As expected, the YFP+ cell population recovered from
mice infected with the wild type MHV68-YFP virus was
substantially enriched for plasma cells compared to unfractionated
splenocytes (Fig. 2D). Because we have previously shown that dose
of M2.Stop virus can impact the phenotype observed [18], we
assessed whether increasing the dose of M2.Stop from 100 to
1,000 pfu would lead to detectable M2.Stop virus infection of
plasma cells. Notably, even following intranasal inoculation with
1,000 pfu of M2.Stop-YFP we failed to observe any YFP+ plasma
cells (data not shown). Thus, we conclude that a significant
percentage of MHV68 infection at the peak of viral latency is
present in plasma cells, and that this population is largely absent in
mice infected with the M2 null virus (M2.Stop-YFP), indicating a
critical role for M2 in plasma cell differentiation during MHV68
chronic infection.
Plasma cells account for the majority of MHV68
reactivation from explanted splenocytes
We noted that the percentage of virus infected splenocytes that
were plasma cells (see Fig. 4C) correlated closely with the
percentage of infected splenocytes that spontaneously reactivate
MHV68 upon explants [13]. To assess whether MHV68
reactivation is linked to plasma cell differentiation, we purified
plasma cells from mice infected with wild type MHV68-YFP and
simultaneously isolated plasma cell-depleted splenocytes (Fig. 5A
and 5B). Subsequent ELISPOT analyses of the purified popula-
tions confirmed appropriate enrichment or depletion of plasma
cells (Fig. 5D).
To determine the frequency of cells in each population
harboring viral genome (a surrogate measure of the frequency of
latently infected cells), the plasma cell enriched and depleted
populations, along with unfractionated splenocytes, were analyzed
for the presence of MHV68 infection using a limiting dilution
nested PCR analysis [13] (Fig. 5C, left panel). This analysis
revealed that there was a slightly higher frequency of viral genome
positive cells in the plasma cell population (approximately 1 in 100
plasma cells) than in either total splenocytes or plasma cell
depleted splenocytes (approximately 1 in 300 cells). Virus
reactivation was examined using a limiting dilution analysis in
which splenocyte populations were plated onto permissive
monolayers of mouse embryo fibroblasts and virus reactivation
scored 2 to 3 weeks post-plating by the appearance of viral
cytopathic effect (cpe) [13]. Notably, this reactivation analysis
revealed a profound difference between the plasma cell enriched
and depleted populations (Fig. 5C, right panel). Approximately
50% of MHV68 infected plasma cells spontaneously reactivated
virus in this assay (approximately 1 in 200 plasma cells reactivated
virus compared to 1 in 100 plasma cells which harbor viral
genome), while only approximately 1% of the virus infected non-
plasma cell population reactivated virus (approximately 1 in
25,000 non-plasma cells reactivated virus compared to 1 in 300 in
this population that harbor viral genome). As expected, approx-
imately 10% of unfractionated splenocytes spontaneously reacti-
vated virus (approximately 1 in 3,000 splenocytes reactivated virus
compared to 1 in 300 harboring viral genome) (Fig. 5C, right
panel). Thus, even though the frequency of infected cells is roughly
the same in the plasma cell and non-plasma cell splenocyte
populations, the frequency of plasma cells reactivating virus is ca.
100-fold higher than the non-plasma cell fraction. These results
are consistent with recent studies characterizing EBV and KSHV
reactivation that have linked plasma cell differentiation to virus
reactivation [8,9,10,11,12]. In light of these results, the nearly
complete absence of the M2 null mutant (M2.Stop-YFP virus) in
splenic plasma cells correlates with the B cell reactivation defect
observed with this mutant virus.
M2 is sufficient to drive plasma cell differentiation of the
BCL-1 B lymphoma cell line
To determine whether M2 plays a direct role in driving plasma
cell differentiation, we utilized the BCL-1 B lymphoma cell line
which can be induced to differentiate into plasma cells by various
stimuli [3,29]. Transient transfection of murine stem cell virus
(MSCV) vectors containing either M2 or a negative control
(MSCV harboring the M2.Stop expression cassette) into the BCL-1
MHV68 M2-Driven Plasma Cell Differentiation
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were infected with a 100 pfu of either MHV68-YFP or M2.Stop-YFP viruses via intranasal inoculation. (A) Total germinal center B cells (CD3
2/B220
+/
GL7
hi/CD95
hi) present in the spleen are reduced in M2.stop-YFP infected mice compared to MHV68-YFP infected mice at day 16. Representative flow
cytometry plots are shown for 3–4 individual mice. (B) Scatter plot depicting the percentage of total B220+ splenocytes that are germinal center B
cells (GL7+/CD95+) in naı ¨ve mice, MHV68-YFP or M2stop-YFP infected spleens at day 16 post-infection. (C) The distribution of wild type and M2 null
virus infected B cells (YFP
+ cells) in the spleens of infected mice. (D) Percentage of wild type and M2 null virus infected (YFP+) B cells vs uninfected B
cells (YFP-) in the spleen that exhibited a germinal center phenotype. (E) Percentage of splenic B cells that were IgG2a+ in wild type vs M2 null virus
infected mice at day 16 post-infection. (F) M2.stop-YFP
+ spleen cells showed an impaired ability to class-switch to IgG2a.
doi:10.1371/journal.ppat.1000677.g003
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(Fig. 6A). M2 expression (monitored by GFP expression) led to
acquisition of a plasmacyte morphology (Fig. 6A), which could be
detected by flow cytometry as an increase in both size and
granularity of the cells (Fig. 6B).
We extended this analysis to examine changes in the expression
of genes associated with the plasma cell differentiation program.
Compared to M2.Stop transfected cells, there was a significant
induction in the levels of transcripts encoding several plasma cell-
associated factors (XBP-1s, Blimp-1, J chain and IRF-4); changes
that were also observed upon LPS stimulation of the BCL-1 cell
line (Fig. 6C). Notably, we repeatedly observed, following
transfection with the M2.Stop vector, lower levels of these plasma
cell-associated transcripts than was observed in untreated BCL-1
cells – suggesting that the transfection protocol leads to selective
loss of those cells in the starting BCL-1 cell population that have
spontaneously differentiated to plasma cells during normal passage
in culture (Fig. 6C). Finally, analysis of the levels of secreted IgM in
the tissue culture supernatants at 48 hours post-treatment or
transfection demonstrated higher levels of secreted IgM in the M2
expressing and LPS treated cultures than in either the M2.Stop
(vector) or untreated cultures (Fig. 6D). Thus, we conclude that
M2 alone is able to drive plasma cell differentiation of the BCL-1
cell line.
Discussion
We have shown here that MHV68 reactivation from splenic B
cells is linked to M2-driven terminal differentiation of B cells to
plasma cells in vivo, supporting previous data that terminal
differentiation into plasma cells is linked to reactivation of the
human gammaherpesviruses KSHV and EBV [8,9,10,11,12]. Our
previous studies have demonstrated that M2 expression in primary
murine B cells in tissue culture was able to drive B cell
Figure 4. Access of MHV68 to the plasma cell reservoir during MHV68 chronic infection requires a functional M2 gene. Mice were
infected with a 100 pfu of either MHV68-YFP or M2.Stop-YFP viruses via intranasal inoculation. (A) The absence of MHV68 infected plasma cells in
mice infected with the M2.Stop-YFP virus. Flow cytometry analyses, gated on YFP+ cells, to determine the presence of virus infected plasma cells
(CD138
+/B220
2) in the spleen at day 16 post-infection. Data shown were compiled from representative wild type (MHV68-YFP) and M2 null virus
(M2.Stop-YFP) infected mice (4 mice per virus). (B) Similar levels of total plasma cells in mice infected with wild type vs. the M2 null MHV68. Compiled
data showing the percentage of plasma cells present in wt MHV68 (MHV68-YFP) infected or M2 null virus (M2.stop-YFP) infected spleen cells at day 16
post-infection. (C) Percentage of plasma cells in virus infected (YFP+) and uninfected (YFP-) splenocytes harvested at day 16 post-infection. (D)
ELISPOT analyses of antibody secreting cells (ASC) present in wt MHV68 (MHV68-YFP) infected splenocytes (YFP+ cells) or bulk splenocytes harvested
at day 16 post-infection.
doi:10.1371/journal.ppat.1000677.g004
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their limited time survival in culture these cells only reached a
phenotype referred to as pre-plasma memory B cells [30]. Previous
studies on the function of M2 suggest a possible mechanism(s) to
drive plasma cell differentiation (Fig. 6E). Madureira et al. [31]
and Rodrigues et al. [23] demonstrated that three PXXP motifs
located in the C-terminal half of M2 play a role in binding Vav1
and Vav2, and that M2 induces phosphorylation of Vav leading to
downstream Rac1 stimulation. Additionally, the M2 protein
harbors 2 tyrosine residues that are predicted to be potential
phosphorylation sites and have been shown to be essential for the
formation of a trimolecular complex with Vav1 and the Src family
kinase Fyn [31]. Notably, it has been shown that Vav knockout
mice have very low levels of serum immunoglobulin and a severe
defect in the induction of Blimp-1 expression [32]. Thus, it seems
likely that under some conditions M2 activation of Vav may lead
to Blimp-1 expression and entry into the plasma cell program
(Fig. 6E). In addition, we have previously shown M2 expression in
primary murine B cells leads to high level IL-10 expression [30].
We have proposed to M2-driven IL-10 expression plays a role in
both driving expansion of latently infected B cells, as well as
suppressing the host immune response during the establishment of
latency [30]. However, it is also possible that M2-driven IL-10
expression plays a direct role in facilitating plasma cell
differentiation. The latter is based on studies that have shown a
role for IL-10 in plasma cell differentiation using model systems
employing human B cells [33,34,35,36]. Finally, as we have shown
here, M2 also upregulates the expression of IRF4 [we have
observed both M2-driven upregulation of IRF4 transcripts
(Fig. 6C) and IRF4 protein (data not shown) in BCL-1 cells].
Induction of IRF4 is of significant interest because it has been
shown to play critical roles in both isotype switching during the
germinal center reaction, and plasma cell differentiation [2,37].
We propose that entry into the plasma cell program results in the
induction of the MHV68 immediate-early transcriptional activator
RTA and subsequent activation of the virus replication cycle
(Fig. 6E). The latter steps are based on the observed ability of the
plasma cell-associated factor XBP-1s to transactivate the critical
viral promoters involved in driving expression of the EBV and
KSHV lytic switch genes [8,9,10,11,12].
DoesM2-driven plasma celldifferentiationplayaroleinMHV68
reactivation from latently infected M12 B lymphoma cells (see
Fig. 1)? We hypothesized that the role of M2 in facilitating TPA
reactivation of the latently infected M12 B cell lines could reflect
TPA induction of M2 expression, leading to sufficient levels of M2
protein to drive plasma cell differentiation and virus reactivation.
This would be consistent with our observation that ectopic
expression of M2 alone is sufficient to drive MHV68 reactivation
from either wt or M2.Stop infected M12 B cell lines (see Fig. 1D).
We have attempted to assess this following TPA stimulation of wild
typeMHV68 infected M12cellsand have been unable to document
any hallmarks of plasma cell differentiation, with the exception of a
modest increase in the levels of secreted IgG (XL and SHS,
unpublished data). This could reflect insufficient sensitivity of the
Figure 5. Plasma cells contribute significantly to spontaneous MHV68 reactivation following explant. (A and B) Purification of plasma
cells and non-plasma cells by flow cytometry. Shown are representative flow plots unsorted (A) and post-sorting (B), as well as the gates used to
isolate the plasma cells and non-plasma cell populations. Cells were sorted from MHV68-YFP infected spleens at day 16 post-infection. (C) Limiting
dilution determinations of the frequency of splenocyte populations harboring the MHV68 genome (left panel) or spontaneously reactivating virus
upon explant (right panel). Splenocytes were harvested from C57Bl/6 mice at day 16 post-infection. For the reactivation analyses, both intact cells
(filled symbols) and mechanically disrupted cells (open symbols) were plated to distinguish the presence of pre-formed infectious virus from
reactivating virus. (D) ELISPOT analyses of antibody secreting cells in the unsorted and purified plasma cell and non-plasma cell populations analyzed
in (A).
doi:10.1371/journal.ppat.1000677.g005
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consistent with this interpretation, suggesting that a small
percentage of cells in the culture differentiate to plasma cells,
secreteIgGandthenperhapsrapidlydisappearduetovirusinduced
cytopathic effect. Alternatively, these results may point to an
independent function of M2 that is also involved in promoting virus
reactivation from latently infected B cells under some conditions.
With respect to the latter possibility, it is clear that plasma cell
differentiation is not the only pathway for gammaherpesvirus
reactivation from latently infected B cells – other stimuli such as
DNA damage can also trigger MHV68 reactivation [38]. A role for
M2 in these responses remains to be determined.
It is notable that loss of M2 leads to alterations in immunoglob-
ulin isotype switching in infected B cells (see Fig. 3E and 3F). These
results are consistent with our previous observation that M2 null
mutants exhibited a significantly slower decay in naı ¨ve B cells
(CD19+/IgD+) compared to wild type MHV68 [18], suggesting
that M2 is involved in driving the differentiation of naı ¨ve B cells.
Similarly, Simas and colleagues noted that the absence of M2 led to
a prolonged persistence of virus infected B cells in germinal centers
[22]. Taken together, these data implicate a role for M2 in
facilitating B cell differentiation through the germinal center
reaction and perhaps directly impacting immunoglobulin isotype
switching. Among the genes that were upregulated upon expression
of M2 in the BCL-1 B lymphoma cell line was the cellular
transcription factor IRF4 (Fig. 6C, and unpublished data), which
has been shown to be required for both isotype switching as well as
plasma cell differentiation [2]. As such, it is possible that M2
modulation of the levels of IRF4 may account for the apparently
distinct roles of M2 in immunoglobulin isotype switching and
plasma cell differentiation. This will require further investigation to
identify the relevant cellular pathways that are manipulated by M2.
Previous studies have demonstrated that M2 is completely
dispensable for virus replication in permissive cell lines, as well as
in the lung following intranasal inoculation [18,39]. However, we
have shown a more rapid clearance of M2 null virus replication in
the spleen following high dose intraperitoneal inoculation (equiv-
alent replication of wild type and M2 null viruses at day 4 post-
infection, and a .20-fold decrease in virus titer of M2 null mutants
compared to wild type MHV68 at day 9 post-infection) [21]. The
basis for the acute replication defect in the spleen is unknown, but
based on a requirement for B cells to seed splenic latency following
intranasal virus inoculation (but not following intraperitoneal
inoculation) [13,40], we have postulated a role for virus reactivation
from latently infected B cells playing a role in seeding acute virus
replication in the spleen. Thus, while high dose intraperitoneal
inoculation bypasses the requirement for B cells to seed initial acute
MHV68 replication in the spleen at day 4 post-infection [13], virus
Figure 6. M2 can drive plasma cell differentiation in a B lymphoma cell line. (A) Appearance of plasmacyte morphology following
transfection of the murine BCL-1 lymphoma cells with a M2 expression vector. GFP fluorescence in BCL-1 lymphoma cells transfected with either
vector control (MSCV-M2.Stop-IRES-GFP) or an M2 expression vector (MSCV-M2-IRES-GFP). GFP expression, driven from an internal ribosome entry site
introduced downstream of the M2 open reading frame, was examined at 24 hr post-transfection. (B) M2 expressing BCL-1 cells exhibited increased
size and granularity compared to M2.Stop transfected cells, as determined by changes in forward and side light scatter. Filled gray histograms were
gated on the GFP expressing cell population in BCL-1 cells transfected with the M2.Stop vector, while the black open histograms were gated on the
GFP expressing cell population in BCL-1 cells transfected with the M2 expression vector. (C) RT-PCR analysis of transcripts associated with the plasma
cell differentiation program. -, untreated BCL-1 cells; LPS, BCL-1 cells treated with 20 ug/ml LPS and RNA prepared at 24 hr post-treatment; V, BCL-1
cells transfected with a control vector (MSCV-M2.Stop-IRES-GFP); M2, BCL-1 cells transfected with an M2 expression vector (MSCV-M2-IRES-GFP). BCL-
1 cells were transfected using a Nucleofector (Amaxa) and RNA prepared at 24 hours post-transfection. (D) Analysis of IgM levels in the tissue culture
supernatant of mock treated vs LPS stimulated, or vector control (MSCV-M2.Stop-IRES-GFP) vs M2 expression vector (MSCV-M2-IRES-GFP) transfected
BCL-1 cells. As indicated, IgM levels were determined at 48 hours post-treatment. (E) Model of M2 induction of plasma cell differentiation leading to
virus reactivation from latency.
doi:10.1371/journal.ppat.1000677.g006
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driving the sustained virus replication observed in the spleen at day
9 post-intraperitoneal inoculation (levels of virus in the spleen at
days 4 and 9 post-infection are equivalent). If so, then the B cell
reactivation defect observed in M2 null virus infected mice would
translate as a late stage acute virus replication defect in the spleen.
Regardless, there is no evidence that M2 plays a direct role in virus
replication. As such, M2 appears to play a specialized role to
facilitate virus reactivation from latently infected B cells.
An alternative model that is worthy of consideration relates to
the impact of M2-driven IL-10 expression on virus-specific CD8+
T cell responses. We have previously shown that loss of M2 leads
to increased levels of virus-specific CD8+ T cells, as assessed using
tetramers to two distinct viral epitopes (ORF6486–498 and
ORF61524–531) expressed during MHV68 replication [30]. Thus,
enhanced CD8+ T cell responses directed against MHV68
replication-associated antigens in M2.Stop infected mice may
result in the rapid clearance of virus infected plasma cells
expressing replication-associated viral antigens - leading to the
observed absence of infected plasma cells at the peak of viral
infection in the spleen. As such, in this model, M2 would not be
expected to be playing a direct role in driving plasma cell
differentiation. We believe that this model is unlikely to account
for the absence of MHV68 infected plasma cells based on the
observed role of M2 in virus reactivation from the MHV68 M12
infected cell lines (see Fig. 1B and 1D), as well as the ability of M2
to drive terminal differentiation of the BCL-1 cell line in culture
(Fig. 6). However, we clearly cannot dismiss a role for enhanced
antiviral CD8+ T cell responses in M2.Stop infected mice in
controlling the frequency of virus infected plasma cells.
Based on the analysis of M2 function, we propose that M2 falls
into a new class of herpesvirus genes that do not directly impact
virus replication, but rather facilitate virus reactivation from
latency by manipulating cellular differentiation/activation leading
to a reactivation competent cellular environment. We have
adopted the term reactivation conditioner for such genes. In the
case of viruses that establish latency in memory lymphocytes, it is
attractive to speculate that it may be necessary to encode functions
that drive quiescent memory B or T cells into a state which is more
conducive to virus replication. With respect to latency established
in memory B cells, plasma cells would appear particularly well
suited to support herpesvirus replication. As such, we hypothesize
that manipulation of plasma cell differentiation leading to virus
reactivation from latently infected memory B cells is relevant to
reactivation of the human gammaherpesviruses. Although there is
no obvious M2 homolog in either EBV or KSHV, there are
several well documented examples of conserved functions encoded
by gammaherpesvirus latency-associate gene products that lack
obvious sequence homology [41]. Indeed, our previous observa-
tion that M2 expression in primary murine B cells triggers IL-6
and IL-10 expression [30], recapitulates functions modulated by
both EBV and KSHV [42,43], and provides further evidence of
pathogenic strategies that are conserved among this family of
viruses. Importantly, our studies provide the impetus to identify
viral gene products encoded by EBV and/or KSHV that
manipulate plasma cell differentiation, which may ultimately
provide new targets for the development of antiviral therapies
against these chronic infections.
Materials and Methods
Viruses, cell culture and reagents
The recombinant viruses, generated as described below, were
passaged and titered as previously described [44]. Murine NIH
3T12 fibroblast cells were cultured in Dulbecco’s modified Eagle
medium supplemented with 10% fetal cal serum, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine. The
M12 B lymphoma cell line was generously provided by Dr. David
Schatz (Yale University School of Medicine, New Haven, CT),
and was cultured in RPMI 1640 medium supplemented with 10%
fetal cal serum, 100 U/ml penicillin, 100 mg/ml streptomycin and
50 mM 2-mercapto-ethanol.
Mice and virus infections
Female C57Bl/6 mice 6 to 8 weeks of age were purchased from
the Jackson Laboratory. Mice were sterile housed and treated
according to Emory University School of Medicine (Atlanta, GA)
guidelines and all animal studies were approved by the Emory
University Institutional Animal Care and Use Committee.
Following sedation, mice were infected intranasally with 100 pfu
of either MHV68-YFP or M2stop-YFP viruses in 20 mL of cMEM.
Mice were allowed to recover from anesthesia before being
returned to their cages.
Generation of recombinant viruses and latently infected
M12 B lymphoma cell lines
The recombinant hygromycin–EGFP-expressing MHV68M2.
Stop viruses (M2.Stop-HE) were generated by allelic exchange using
a previously described MHV68-BAC containing a hygromycin-
EGFP fusion gene under the control of the HCMV immediate-early
promoter in the ORF27/29b locus (MHV68-HE BAC) [38] and a
targeting vector containing the M2 gene with a translation stop and
frame shift incorporated at bp 4,559 of the viral genome (pGS284/
M2stop) as previously described [45]. To establish MHV68 latently
infected M12 cell lines, M12 cells were infected with WT-HE or
M2stop-HE viruses by spinoculation at 1,800 rpm for 90 min and
then subjected to hygromycin (400 mg/ml) selection. The individual
clonal cell lines were established by limiting dilution cloning, and the
presence of episomal copies of the MHV68 genome confirmed by
Gardella gel electrophoresis [46].
Immunoblot analyses and plaque assays
Cells were lysed with RIPA buffer (150 mM NaCl, 20 mM
Tris.Cl, 2 mM EDTA, 1% NP-40 supplemented with EDTA-free
protease inhibitor) (Roche). The whole cell lysates were resolved
by SDS-PAGE gel electrophoresis, transferred to nitrocellulose
membranes and immunoblotting with chicken anti-ORF59 or
rabbit anti-MHV68 antiserum [38]. Plaque assays were performed
in NIH3T12 fibroblast cells as previously described [38]. Briefly,
cells and supernatants were collected at various times post-
induction with TPA (20 ng/ml) and frozen at 280uC. Samples
were then subjected to two cycles of freezing and thawing, and
virus titers were quantitated by plaque assay on NIH 3T12
fibroblasts.
RNA isolation and RT-PCR
Total RNA was isolated from untreated or treated cells using
TRIzol per manufacturer’s protocol (Invitrogen). 2 mg RNA was
used for first-strand cDNA synthesis (Invitrogen), followed by PCR
amplification using the appropriate oligonucleotide primers as
previously described [38]. The primers used for the detection of
plasma cell-associated transcripts in BCL-1 cells were as follows;
specific spliced XBP-1(s): 59-GTAGCAGCGCAGACTGCTCGA-
GATAG-39 and 59-GAGGTGCACATAGTCTGCACCAGC-39,
unspliced XBP-1(u): 59-GTAGCAGCGCAGACTGC TCGAGA-
TAG-39 and 59-AGTGCTGCGGACTCAGCAGACCCGGC-39,
J chain: 59-ATGAAGACC CACCTGCTTCTC-39 and 59-GT-
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GA GACGGGCAGCCGGGGC-39 and 59-TCACTCTTGGA
TGGAAGAATGACGGAGGGA-39, Blimp-1: 59-GGAGGATC-
TGACCCGAATCA-39 and 59-CTCCACCATGGAGGTCACA-
TC, M2: 59-ATGG GCCCAACACCCCCACAAGGAAAG-39
and 59-TTACTCCTCGCCCCACTCCACAAAACC-39, actin:
59-TAAGTGGTTACAGGAA G-39 and 59-AGCCTTCATACA-
TCAAG-39. All primers employed were designed to amplify spliced
gene products and, as such, any products arising from contaminat-
ing DNA would run at a larger size (not detected).
Limiting dilution assays to determine frequency of cells
harboring viral genome and reactivating virus
The frequency of MHV68 genome-positive cells was deter-
mined using a previously described nested PCR assay (LD-PCR)
[13]. Briefly, cells were counted, resuspended in an isotonic
solution, and diluted into a background of 10
4 uninfected NIH
3T12 cells. Following cell lysis with proteinase K, two rounds of
nested PCR were performed on each sample to detect the
presence of the MHV68 ORF50. To ensure sufficient sensitivity of
the nested PCR reaction, 10, 1, or 0.1 copies of a gene 50
containing plasmid (pBamHI N) were diluted into a background of
10
4 uninfected cells and analyzed in parallel with the experimental
sample. The frequency of MHV68 reactivation from latency was
also detected as previously described [13]. Briefly, cells were plated
in a series of twofold dilutions onto MEF monolayers in 96-well
tissue culture plates. After 21 days, wells were scored microscop-
ically for the presence of viral cytopathic effect (CPE). To detect
preformed infectious virus, parallel samples were subjected to
mechanical disruption as previously described [13], a process that
kills .99% of cells without affecting the preformed MHV68
virions [13]. Disrupted cells were plated in a similar series of
twofold dilutions.
Flow cytometry
Flow cytometry analyses for murine splenic cells were done as
previously described [30] with the following antibodies: GL-7-
Biotin, Stratavidin-APC, CD95-PE, CD138-PE, B220-Pacific Blue
(CALTAG Laboratories), CD19-FITC, CD3e-PerCP, IgG2a-
Biotin (BD Pharmingen, except where noted). The data were
collected on a LSRII flow cytometer (BD Biosciences). For
purification of plasma cells, single-cell suspensions were isolated
from infected spleens at day 16 post-infection with 100 pfu of the
MHV68-YFP recombinant virus administered via intranasal
inoculation. The cells were labeled with CD138-PE and B220-
Pacific Blue on ice for 20 min, followed by washing with 1% BSA/
PBS. The stained cell populations were then sorted on either a
FACSVantage or FACSAria
TM II flow cytometer (BD Bioscienc-
es). For purification of YFP+ cell populations, the single cell
suspensions were directly subjected to separation on a FACSVan-
tage and FACSAria
TM II flow cytometer (BD Bioscience).
Enzyme-linked immunosorbent assays (ELISAs) and
enzyme-linked immunosorbent spot (ELISPOT) analyses
ELISA for IgM secretion was performed as per manufacturer’s
protocol (Bethyl Laboratory). To analyze antibody secretion from
sorted YFP+ or plasma cell populations, mouse IgG capture
antibodies were coated onto a PVDF-backed microplate. The
sorted cell populations were plated onto blocked plates at serial
dilution and incubated in a humidified 37uCC O 2 incubator for
overnight. The wells were washed and bound antibodies were
detected with anti-mouse IgG antibodies. The spots were counted
using automated ELISPOT reader.
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